Peter McPartland
Vorstandsvorsitzender bei Reacta Biotech Ltd.
Profil
Peter McPartland is the founder of Reacta Biotech Ltd.
which was founded in 2013, where he holds the title of Managing Director.
He is also the founder of SV Health Investors LLP.
Currently, he holds the position of Investment Director at Martlet Capital since 2019 and Director at GKMH Ltd.
since 2020.
In the past, he worked as a Director at Triangle Pharmaceuticals, Inc. and Shire Pharmaceuticals Ltd., Finance Director at Forte Medical Ltd., and Director at Chiroscience Ltd.
He also served as a Non-Executive Director at Redx Pharma Plc from 2010 to 2017.
Aktive Positionen von Peter McPartland
| Unternehmen | Position | Beginn |
|---|---|---|
Reacta Biotech Ltd.
 Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Vorstandsvorsitzender | 01.06.2013 |
Martlet Capital
 Martlet Capital Investment ManagersFinance Martlet Capital (Marlet Capital) is a venture capital subsidiary of Marshall of Cambridge (Holdings) Ltd founded in 2011 by Peter Lawton Cowley and Robert Marshall. The firm is headquartered in Cambridge, United Kingdom. | Private Equity Investor | 01.09.2019 |
GKMH Ltd.
 GKMH Ltd. Miscellaneous Commercial ServicesCommercial Services GKMH Ltd. is a company based in Newmarket, UK. The British company was founded in 2019. | Direktor/Vorstandsmitglied | 27.10.2020 |
Ehemalige bekannte Positionen von Peter McPartland
| Unternehmen | Position | Ende |
|---|---|---|
| REDX PHARMA PLC | Direktor/Vorstandsmitglied | 20.04.2017 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Direktor/Vorstandsmitglied | - |
| Chiroscience Ltd. | Direktor/Vorstandsmitglied | - |
Shire Pharmaceuticals Ltd.
 Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Direktor/Vorstandsmitglied | - |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REDX PHARMA PLC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Forte Medical Ltd.
 Forte Medical Ltd. Medical SpecialtiesHealth Technology Forte Medical Ltd. operates as a specimen collection company. It manufactures and sells medtech devices. The company was founded by Vincent John Charles Forte and Giovanna Forte and is headquartered in London, the United Kingdom. | Health Technology |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Health Technology |
| Chiroscience Ltd. | |
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Commercial Services |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Martlet Capital
Martlet Capital Investment ManagersFinance Martlet Capital (Marlet Capital) is a venture capital subsidiary of Marshall of Cambridge (Holdings) Ltd founded in 2011 by Peter Lawton Cowley and Robert Marshall. The firm is headquartered in Cambridge, United Kingdom. | Finance |
GKMH Ltd.
GKMH Ltd. Miscellaneous Commercial ServicesCommercial Services GKMH Ltd. is a company based in Newmarket, UK. The British company was founded in 2019. | Commercial Services |
